These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9894374

  • 1. Improved tolerability of felodipine compared with amlodipine in elderly hypertensives: a randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events. The International Study Group.
    Schaefer RM, Aldons PM, Burgess ED, Tilvis R, Girerd X, Singh GP, Rehn L, Morgan TO.
    Int J Clin Pract; 1998 Sep; 52(6):381-6. PubMed ID: 9894374
    [Abstract] [Full Text] [Related]

  • 2. Office and ambulatory blood pressure: a comparison between amlodipine and felodipine ER. Danish Multicentre Group.
    Høegholm A, Wiinberg N, Rasmussen E, Nielsen PE.
    J Hum Hypertens; 1995 Aug; 9(8):611-6. PubMed ID: 8523374
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of amlodipine and felodipine ER on office and ambulatory blood pressure in patients with mild to moderate hypertension. Danish Multicentre Group.
    Høegholm A, Wiinberg N, Rasmussen E, Nielsen PE.
    J Hum Hypertens; 1995 Mar; 9 Suppl 1():S25-8. PubMed ID: 7783110
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J, Poirier L, Archambault F, Jewell D, Reed CV, Lacourcière Y.
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC, Haggert BE, Liss C.
    Clin Ther; 1994 May; 16(4):634-46. PubMed ID: 7982251
    [Abstract] [Full Text] [Related]

  • 6. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
    Chan JC, Critchley JA, Lappe JT, Raskin SJ, Snavely D, Goldberg AI, Sweet CS.
    J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
    [Abstract] [Full Text] [Related]

  • 7. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
    Dahlöf B, Jönsson L, Borgholst O, Ekblad G, Engstrand C, Grundestam I, Lindh A.
    Blood Press Suppl; 1993 Sep; 1():37-45. PubMed ID: 8173689
    [Abstract] [Full Text] [Related]

  • 8. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B, Hosie J.
    Blood Press Suppl; 1993 Apr; 1():22-9. PubMed ID: 8173687
    [Abstract] [Full Text] [Related]

  • 10. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W, Wilson T.
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [Abstract] [Full Text] [Related]

  • 11. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH, Hainer JW, Sugg J, M-FACT Study Group.
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [Abstract] [Full Text] [Related]

  • 12. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 13. Felodipine once daily in elderly hypertensives. Binational MC Study Group (United Kingdom and Netherlands).
    Hosie J, Mulder AW, Westberg B.
    J Hum Hypertens; 1991 Feb; 5(1):49-53. PubMed ID: 2041036
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 15. Low dosages of felodipine ER once daily as monotherapy in elderly hypertensive patients: effect on ambulatory blood pressure and quality of life.
    van Ree JW, van der Pol GA.
    J Hum Hypertens; 1996 Sep; 10(9):613-8. PubMed ID: 8953207
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive effect and tolerability of felodipine extended release (ER) tablets in comparison with felodipine plain tablets (PT) and placebo in hypertensives on a diuretic. Canadian Study Group.
    Carruthers SG, Vint-Reed C.
    Clin Invest Med; 1993 Oct; 16(5):386-94. PubMed ID: 8261692
    [Abstract] [Full Text] [Related]

  • 17. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G, Italian Study Group on Nilvadipine in Mild to Moderate Hypertension.
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [Abstract] [Full Text] [Related]

  • 18. Crossover comparison of the pharmacokinetics of amlodipine and felodipine ER in hypertensive patients.
    Videbaek LM, Jacobsen IA.
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):514-8. PubMed ID: 9401833
    [Abstract] [Full Text] [Related]

  • 19. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.
    Hoffmann J.
    Blood Press Suppl; 1993 Nov; 1():30-6. PubMed ID: 8173688
    [Abstract] [Full Text] [Related]

  • 20. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L, Hiremath, Kerkar PG, Manade VG.
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.